PARAMETRIC PORTFOLIO ASSOCIATES LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$6,723,000
+5.8%
534,384
-1.9%
0.00%
+33.3%
Q4 2021$6,352,000
+5.0%
544,769
+17.6%
0.00%0.0%
Q3 2021$6,049,000
+25.8%
463,155
+24.0%
0.00%0.0%
Q2 2021$4,807,000
+135.6%
373,486
+104.7%
0.00%
+200.0%
Q1 2021$2,040,000
-22.0%
182,431
-20.5%
0.00%
-50.0%
Q4 2020$2,614,000
+47.1%
229,466
+16.1%
0.00%
+100.0%
Q3 2020$1,777,000
+11.8%
197,588
+28.3%
0.00%0.0%
Q2 2020$1,589,000
+24.5%
154,009
+21.8%
0.00%0.0%
Q1 2020$1,276,000
-51.4%
126,425
-35.9%
0.00%
-50.0%
Q4 2019$2,625,000
+277.2%
197,198
+143.2%
0.00%
+100.0%
Q3 2019$696,000
+1.6%
81,086
+29.5%
0.00%0.0%
Q2 2019$685,000
-3.1%
62,608
+19.8%
0.00%0.0%
Q1 2019$707,000
+39.7%
52,255
+6.9%
0.00%0.0%
Q4 2018$506,000
-63.8%
48,886
-35.5%
0.00%0.0%
Q3 2018$1,399,000
-11.2%
75,787
-8.1%
0.00%0.0%
Q2 2018$1,576,000
+45.0%
82,448
+17.1%
0.00%0.0%
Q1 2018$1,087,000
-5.7%
70,417
-8.5%
0.00%0.0%
Q4 2017$1,153,000
+12.6%
76,937
+18.5%
0.00%0.0%
Q3 2017$1,024,000
-15.4%
64,930
+1.3%
0.00%0.0%
Q2 2017$1,211,000
-12.1%
64,121
-20.5%
0.00%
-50.0%
Q1 2017$1,377,000
+15.8%
80,693
+3.7%
0.00%0.0%
Q4 2016$1,189,000
+24.0%
77,780
+28.8%
0.00%
+100.0%
Q3 2016$959,000
+21.4%
60,386
-0.0%
0.00%0.0%
Q2 2016$790,000
+33.0%
60,395
+11.3%
0.00%0.0%
Q1 2016$594,000
+18.6%
54,255
+25.5%
0.00%0.0%
Q4 2015$501,000
-11.8%
43,237
-20.6%
0.00%0.0%
Q3 2015$568,000
-25.9%
54,487
-14.4%
0.00%0.0%
Q2 2015$767,000
-39.5%
63,631
-19.7%
0.00%
-66.7%
Q1 2015$1,268,000
+16.7%
79,222
+11.6%
0.00%
+50.0%
Q4 2014$1,087,000
+69.8%
70,977
+43.7%
0.00%
+100.0%
Q3 2014$640,000
-19.2%
49,405
-4.4%
0.00%
-50.0%
Q2 2014$792,000
+160.5%
51,679
+109.2%
0.00%
+100.0%
Q1 2014$304,000
+49.8%
24,698
+41.1%
0.00%
Q4 2013$203,000
+33.6%
17,507
+36.2%
0.00%
Q3 2013$152,000
+47.6%
12,854
+23.8%
0.00%
Q2 2013$103,00010,3840.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders